L. Montalvo et al., Effect of flutamide-induced androgen-receptor blockade on adenylate cyclase activation through G-protein coupled receptors in rat prostate, CELL SIGNAL, 12(5), 2000, pp. 311-316
The effect of the antiandrogen flutamide on the prostatic vasoactive intest
inal peptide (VIP) receptor/effector system was studied in rats. Rats were
s.c. injected with a daily dose of flutamide (15 mg/kg B.W.) or vehicle for
14 days. Drug treatment resulted in histological evidence of gland involut
ion and increased plasma membrane fluidity as estimated by fluorescence spe
ctroscopy. The number of VIP receptors and the stimulatory effect of VIP on
adenylate cyclase activity in prostatic membranes decreased in flutamide-t
reated rats. However, the pattern of forskolin stimulation of the enzyme ac
tivity was not modified by this drug. Androgen-receptor blockade by flutami
de also decreased the prostatic levels of alpha(s), alpha(i1/2), and alpha(
i3/0), G-protein subunits, as estimated by an immunological procedure. Wher
eas apoptotic DNA fragmentation was evidenced in prostate from 3-day castra
ted animals, a heterogeneous electrophoretic pattern was observed after flu
tamide treatment. Thus, androgen-receptor blockade by flutamide results in
an important impairment of the components of the VIP receptor/effector syst
em in rat prostate as well as in a modification of their coupling extent, w
hich is presumably due to differences observed in plasma membrane fluidity.
These results represent a crosstalk in the prostate between two mechanisms
of signal transduction involved in cell proliferation. (C) 2000 Elsevier S
cience Inc. All rights reserved.